SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Vassilis G. Koutkias, Marie-Christine Jaulent, Computational Approaches for Pharmacovigilance Signal Detection: Toward Integrated and Semantically-Enriched Frameworks, Drug Safety, 2015, 38, 3, 219

    CrossRef

  2. 2
    Vaishali K. Patadia, Martijn J. Schuemie, Preciosa Coloma, Ron Herings, Johan van der Lei, Sabine Straus, Miriam Sturkenboom, Gianluca Trifirò, Evaluating performance of electronic healthcare records and spontaneous reporting data in drug safety signal detection, International Journal of Clinical Pharmacy, 2015, 37, 1, 94

    CrossRef

  3. 3
    Kristina Star, Sarah Watson, Lovisa Sandberg, Jeanette Johansson, I. Ralph Edwards, Longitudinal medical records as a complement to routine drug safety signal analysis, Pharmacoepidemiology and Drug Safety, 2015, 24, 4
  4. 4
    S. Cederholm, G. Hill, A. Asiimwe, A. Bate, F. Bhayat, G. Persson Brobert, T. Bergvall, D. Ansell, K. Star, G. N. Norén, Structured Assessment for Prospective Identification of Safety Signals in Electronic Medical Records: Evaluation in the Health Improvement Network, Drug Safety, 2015, 38, 1, 87

    CrossRef

  5. 5
    Vaishali K Patadia, Preciosa Coloma, Martijn J Schuemie, Ron Herings, Rosa Gini, Giampiero Mazzaglia, Gino Picelli, Carla Fornari, Lars Pedersen, Johan van der Lei, Miriam Sturkenboom, Gianluca Trifirò, Using real-world healthcare data for pharmacovigilance signal detection – the experience of the EU-ADR project, Expert Review of Clinical Pharmacology, 2015, 8, 1, 95

    CrossRef

  6. 6
    Joshua J. Gagne, Shirley V. Wang, Jeremy A. Rassen, Sebastian Schneeweiss, A modular, prospective, semi-automated drug safety monitoring system for use in a distributed data environment, Pharmacoepidemiology and Drug Safety, 2014, 23, 6
  7. 7
    SriJyothsna Yeleswarapu, Aditya Rao, Thomas Joseph, Vangala Saipradeep, Rajgopal Srinivasan, A pipeline to extract drug-adverse event pairs from multiple data sources, BMC Medical Informatics and Decision Making, 2014, 14, 1, 13

    CrossRef

  8. 8
    David Madigan, Paul E. Stang, Jesse A. Berlin, Martijn Schuemie, J. Marc Overhage, Marc A. Suchard, Bill Dumouchel, Abraham G. Hartzema, Patrick B. Ryan, A Systematic Statistical Approach to Evaluating Evidence from Observational Studies, Annual Review of Statistics and Its Application, 2014, 1, 1, 11

    CrossRef

  9. 9
    Igor Grigoriev, Wolfgang zu Castell, Philipp Tsvetkov, Alexey V. Antonov, AERS spider: an online interactive tool to mine statistical associations in Adverse Event Reporting System, Pharmacoepidemiology and Drug Safety, 2014, 23, 8
  10. 10
    A. Ruigómez, R. Brauer, L. A. García Rodríguez, C. Huerta, G. Requena, M. Gil, Francisco de Abajo, G. Downey, A. Bate, M. Feudjo Tepie, M. de Groot, R. Schlienger, R. Reynolds, O. Klungel, Ascertainment of acute liver injury in two European primary care databases, European Journal of Clinical Pharmacology, 2014, 70, 10, 1227

    CrossRef

  11. 11
    Francois Maignen, Manfred Hauben, Eric Hung, Lionel Van Holle, Jean-Michel Dogne, Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases, Pharmacoepidemiology and Drug Safety, 2014, 23, 2
  12. 12
    G. Trifirò, P. M. Coloma, P. R. Rijnbeek, S. Romio, B. Mosseveld, D. Weibel, J. Bonhoeffer, M. Schuemie, J. Lei, M. Sturkenboom, Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?, Journal of Internal Medicine, 2014, 275, 6
  13. 13
    Cédric Bousquet, Éric Sadou, Julien Souvignet, Marie-Christine Jaulent, Gunnar Declerck, Formalizing MedDRA to support semantic reasoning on adverse drug reaction terms, Journal of Biomedical Informatics, 2014, 49, 282

    CrossRef

  14. 14
    Ning Shang, Hua Xu, Thomas C. Rindflesch, Trevor Cohen, Identifying plausible adverse drug reactions using knowledge extracted from the literature, Journal of Biomedical Informatics, 2014, 52, 293

    CrossRef

  15. 15
    S. V. Iyer, R. Harpaz, P. LePendu, A. Bauer-Mehren, N. H. Shah, Mining clinical text for signals of adverse drug-drug interactions, Journal of the American Medical Informatics Association, 2014, 21, 2, 353

    CrossRef

  16. 16
    Carmen Ferrajolo, Annalisa Capuano, Gianluca Trifirò, Ugo Moretti, Francesco Rossi, Carmela Santuccio, Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001 – 2012, Expert Opinion on Drug Safety, 2014, 13, S1, 9

    CrossRef

  17. 17
    T. J. Urban, D. B. Goldstein, Pharmacogenetics at 50: Genomic Personalization Comes of Age, Science Translational Medicine, 2014, 6, 220, 220ps1

    CrossRef

  18. 18
    Zeinab Awada, Nathalie Khoueiry Zgheib, Pharmacogenovigilance: a pharmacogenomics pharmacovigilance program, Pharmacogenomics, 2014, 15, 6, 845

    CrossRef

  19. 19
    Paolo Baldo, Paolo De Paoli, Pharmacovigilance in oncology: evaluation of current practice and future perspectives, Journal of Evaluation in Clinical Practice, 2014, 20, 5
  20. 20
    Carmen Ferrajolo, Preciosa M. Coloma, Katia M. C. Verhamme, Martijn J. Schuemie, Sandra de Bie, Rosa Gini, Ron Herings, Giampiero Mazzaglia, Gino Picelli, Carlo Giaquinto, Lorenza Scotti, Paul Avillach, Lars Pedersen, Francesco Rossi, Annalisa Capuano, Johan van der Lei, Gianluca Trifiró, Miriam C. J. M. Sturkenboom, Signal Detection of Potentially Drug-Induced Acute Liver Injury in Children Using a Multi-Country Healthcare Database Network, Drug Safety, 2014, 37, 2, 99

    CrossRef

  21. 21
    R W White, R Harpaz, N H Shah, W DuMouchel, E Horvitz, Toward Enhanced Pharmacovigilance Using Patient-Generated Data on the Internet, Clinical Pharmacology & Therapeutics, 2014, 96, 2
  22. 22
    Vera E. Valkhoff, Preciosa M. Coloma, Gwen M.C. Masclee, Rosa Gini, Francesco Innocenti, Francesco Lapi, Mariam Molokhia, Mees Mosseveld, Malene Schou Nielsson, Martijn Schuemie, Frantz Thiessard, Johan van der Lei, Miriam C.J.M. Sturkenboom, Gianluca Trifirò, Validation study in four health-care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug-related upper gastrointestinal bleeding risk, Journal of Clinical Epidemiology, 2014, 67, 8, 921

    CrossRef

  23. 23
    Patrick B. Ryan, Paul E. Stang, J. Marc Overhage, Marc A. Suchard, Abraham G. Hartzema, William DuMouchel, Christian G. Reich, Martijn J. Schuemie, David Madigan, A Comparison of the Empirical Performance of Methods for a Risk Identification System, Drug Safety, 2013, 36, S1, 143

    CrossRef

  24. 24
    Preciosa M. Coloma, Paul Avillach, Francesco Salvo, Martijn J. Schuemie, Carmen Ferrajolo, Antoine Pariente, Annie Fourrier-Réglat, Mariam Molokhia, Vaishali Patadia, Johan van der Lei, Miriam Sturkenboom, Gianluca Trifirò, A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection Using Electronic Healthcare Record Databases, Drug Safety, 2013, 36, 1, 13

    CrossRef

  25. 25
    R. Harpaz, S. Vilar, W. DuMouchel, H. Salmasian, K. Haerian, N. H. Shah, H. S. Chase, C. Friedman, Combing signals from spontaneous reports and electronic health records for detection of adverse drug reactions, Journal of the American Medical Informatics Association, 2013, 20, 3, 413

    CrossRef

  26. You have free access to this content26
    Fadi Almasalha, Dianhui Xu, Gail M. Keenan, Ashfaq Khokhar, Yingwei Yao, Yu-C. Chen, Andy Johnson, R. Ansari, Diana J. Wilkie, Data Mining Nursing Care Plans of End-of-Life Patients: A Study to Improve Healthcare Decision Making, International Journal of Nursing Knowledge, 2013, 24, 1
  27. 27
    Patrick B. Ryan, Martijn J. Schuemie, Emily Welebob, Jon Duke, Sarah Valentine, Abraham G. Hartzema, Defining a Reference Set to Support Methodological Research in Drug Safety, Drug Safety, 2013, 36, S1, 33

    CrossRef

  28. 28
    J. Marc Overhage, Patrick B. Ryan, Martijn J. Schuemie, Paul E. Stang, Desideratum for Evidence Based Epidemiology, Drug Safety, 2013, 36, S1, 5

    CrossRef

  29. 29
    P. Avillach, J.-C. Dufour, G. Diallo, F. Salvo, M. Joubert, F. Thiessard, F. Mougin, G. Trifiro, A. Fourrier-Reglat, A. Pariente, M. Fieschi, Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR project, Journal of the American Medical Informatics Association, 2013, 20, 3, 446

    CrossRef

  30. 30
    K. Sai, T. Hanatani, Y. Azuma, K. Segawa, M. Tohkin, H. Omatsu, H. Makimoto, M. Hirai, Y. Saito, Development of a detection algorithm for statin-induced myopathy using electronic medical records, Journal of Clinical Pharmacy and Therapeutics, 2013, 38, 3
  31. 31
    Patrick B. Ryan, Martijn J. Schuemie, Susan Gruber, Ivan Zorych, David Madigan, Empirical Performance of a New User Cohort Method: Lessons for Developing a Risk Identification and Analysis System, Drug Safety, 2013, 36, S1, 59

    CrossRef

  32. 32
    Patrick B. Ryan, Martijn J. Schuemie, David Madigan, Empirical Performance of a Self-Controlled Cohort Method: Lessons for Developing a Risk Identification and Analysis System, Drug Safety, 2013, 36, S1, 95

    CrossRef

  33. 33
    Marc A. Suchard, Ivan Zorych, Shawn E. Simpson, Martijn J. Schuemie, Patrick B. Ryan, David Madigan, Empirical Performance of the Self-Controlled Case Series Design: Lessons for Developing a Risk Identification and Analysis System, Drug Safety, 2013, 36, S1, 83

    CrossRef

  34. 34
    P. Avillach, P. M. Coloma, R. Gini, M. Schuemie, F. Mougin, J.-C. Dufour, G. Mazzaglia, C. Giaquinto, C. Fornari, R. Herings, M. Molokhia, L. Pedersen, A. Fourrier-Reglat, M. Fieschi, M. Sturkenboom, J. van der Lei, A. Pariente, G. Trifiro, Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project, Journal of the American Medical Informatics Association, 2013, 20, 1, 184

    CrossRef

  35. 35
    Carmen Ferrajolo, Katia M. C. Verhamme, Gianluca Trifirò, Geert W. ‘t Jong, Carlo Giaquinto, Gino Picelli, Alessandro Oteri, Sandra de Bie, Vera E. Valkhoff, Martijn J. Schuemie, Giampiero Mazzaglia, Claudio Cricelli, Francesco Rossi, Annalisa Capuano, Miriam C. J. M. Sturkenboom, Idiopathic Acute Liver Injury in Paediatric Outpatients: Incidence and Signal Detection in Two European Countries, Drug Safety, 2013, 36, 10, 1007

    CrossRef

  36. 36
    R Harpaz, W DuMouchel, P LePendu, A Bauer-Mehren, P Ryan, N H Shah, Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System, Clinical Pharmacology & Therapeutics, 2013, 93, 6
  37. 37
    P LePendu, S V Iyer, A Bauer-Mehren, R Harpaz, J M Mortensen, T Podchiyska, T A Ferris, N H Shah, Pharmacovigilance Using Clinical Notes, Clinical Pharmacology & Therapeutics, 2013, 93, 6
  38. 38
    Preciosa M. Coloma, Gianluca Trifirò, Vaishali Patadia, Miriam Sturkenboom, Postmarketing Safety Surveillance, Drug Safety, 2013, 36, 3, 183

    CrossRef

  39. 39
    José Luis Oliveira, Pedro Lopes, Tiago Nunes, David Campos, Scott Boyer, Ernst Ahlberg, Erik M. Mulligen, Jan A. Kors, Bharat Singh, Laura I. Furlong, Ferran Sanz, Anna Bauer-Mehren, Maria C. Carrascosa, Jordi Mestres, Paul Avillach, Gayo Diallo, Carlos Díaz Acedo, Johan Lei, The EU-ADR Web Platform: delivering advanced pharmacovigilance tools, Pharmacoepidemiology and Drug Safety, 2013, 22, 5
  40. 40
    Paul E. Stang, Patrick B. Ryan, J. Marc Overhage, Martijn J. Schuemie, Abraham G. Hartzema, Emily Welebob, Variation in Choice of Study Design: Findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) Survey, Drug Safety, 2013, 36, S1, 15

    CrossRef

  41. 41
    Thomas E. Grissom, Andrew DuKatz, Hubert A. Kordylewski, Richard P. Dutton, Methods, Models, and Computation for Medical Informatics, 2013,

    CrossRef

  42. You have free access to this content42
    James T. Walkup, Lisa Townsend, Stephen Crystal, Mark Olfson, A systematic review of validated methods for identifying suicide or suicidal ideation using administrative or claims data, Pharmacoepidemiology and Drug Safety, 2012, 21,
  43. 43
    Yunn-Fang Ho, Ling-Ling Hsieh, Wan-Chen Lu, Fu-Chang Hu, Kenneth M. Hale, Shu-Jen Lee, Fang-Ju Lin, Appropriateness of ambulatory prescriptions in Taiwan: translating claims data into initiatives, International Journal of Clinical Pharmacy, 2012, 34, 1, 72

    CrossRef

  44. 44
    K Haerian, D Varn, S Vaidya, L Ena, H S Chase, C Friedman, Detection of Pharmacovigilance-Related Adverse Events Using Electronic Health Records and Automated Methods, Clinical Pharmacology & Therapeutics, 2012, 92, 2
  45. 45
    Shelly Sachdeva, Aastha Madaan, Subhash Bhalla, Discovery of Patterns to Improve Usability of Electronic Health Record Systems, Journal of Information Processing, 2012, 20, 1, 327

    CrossRef

  46. 46
    Peter M. Wahl, Joshua J. Gagne, Thomas E. Wasser, Debra F. Eisenberg, J. Keith Rodgers, Gregory W. Daniel, Marcus Wilson, Sebastian Schneeweiss, Jeremy A. Rassen, Amanda R. Patrick, Jerry Avorn, Rhonda L. Bohn, Early Steps in the Development of a Claims-Based Targeted Healthcare Safety Monitoring System and Application to Three Empirical Examples, Drug Safety, 2012, 35, 5, 407

    CrossRef

  47. 47
    Preciosa M. Coloma, Gianluca Trifirò, Martijn J. Schuemie, Rosa Gini, Ron Herings, Julia Hippisley-Cox, Giampiero Mazzaglia, Gino Picelli, Giovanni Corrao, Lars Pedersen, Johan Lei, Miriam Sturkenboom, Electronic healthcare databases for active drug safety surveillance: is there enough leverage?, Pharmacoepidemiology and Drug Safety, 2012, 21, 6
  48. 48
    Vassilis Koutkias, Vassilis Kilintzis, George Stalidis, Katerina Lazou, Julie Niès, Ludovic Durand-Texte, Peter McNair, Régis Beuscart, Nicos Maglaveras, Knowledge engineering for adverse drug event prevention: On the design and development of a uniform, contextualized and sustainable knowledge-based framework, Journal of Biomedical Informatics, 2012, 45, 3, 495

    CrossRef

  49. 49
    Andrew Tomlin, David Reith, Susan Dovey, Murray Tilyard, Methods for Retrospective Detection of Drug Safety Signals and Adverse Events in Electronic General Practice Records, Drug Safety, 2012, 35, 9, 733

    CrossRef

  50. 50
    Andrew Tomlin, David Reith, Susan Dovey, Murray Tilyard, Methods for Retrospective Detection of Drug Safety Signals and Adverse Events in Electronic General Practice Records, Drug Safety, 2012, 35, 9, 733

    CrossRef

  51. 51
    Marc Suling, Iris Pigeot, Signal Detection and Monitoring Based on Longitudinal Healthcare Data, Pharmaceutics, 2012, 4, 4, 607

    CrossRef

  52. 52
    Thomas E. Grissom, Andrew DuKatz, Hubert A. Kordylewski, Richard P. Dutton, Bring Out Your Data, International Journal of Computational Models and Algorithms in Medicine, 2011, 2, 2, 51

    CrossRef

  53. 53
    Preciosa M. Coloma, Martijn J. Schuemie, Gianluca Trifirò, Rosa Gini, Ron Herings, Julia Hippisley-Cox, Giampiero Mazzaglia, Carlo Giaquinto, Giovanni Corrao, Lars Pedersen, Johan van der Lei, Miriam Sturkenboom, Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project, Pharmacoepidemiology and Drug Safety, 2011, 20, 1
  54. 54
    Lixia Yao, Yiye Zhang, Yong Li, Philippe Sanseau, Pankaj Agarwal, Electronic health records: Implications for drug discovery, Drug Discovery Today, 2011, 16, 13-14, 594

    CrossRef

  55. 55
    Antoine Pariente, Marie Didailler, Paul Avillach, Ghada Miremont-Salamé, Annie Fourrier-Reglat, Françoise Haramburu, Nicholas Moore, A potential competition bias in the detection of safety signals from spontaneous reporting databases, Pharmacoepidemiology and Drug Safety, 2010, 19, 11
  56. 56
    Ricard Garcia-Serna, Jordi Mestres, Anticipating drug side effects by comparative pharmacology, Expert Opinion on Drug Metabolism & Toxicology, 2010, 6, 10, 1253

    CrossRef

  57. You have free access to this content57
    Alain Weill, Michel Païta, Philippe Tuppin, Jean-Paul Fagot, Anke Neumann, Dominique Simon, Philippe Ricordeau, Jean-Louis Montastruc, Hubert Allemand, Benfluorex and valvular heart disease: a cohort study of a million people with diabetes mellitus, Pharmacoepidemiology and Drug Safety, 2010, 19, 12
  58. 58
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2010, 19, 5
  59. 59
    Richard Pushkin, Lynda Frassetto, Candy Tsourounis, Eleanor S. Segal, Stephanie Kim, Improving the Reporting of Adverse Drug Reactions in the Hospital Setting, Postgraduate Medicine, 2010, 122, 6, 154

    CrossRef

  60. 60
    Jeffrey A. Linder, Jennifer S. Haas, Aarthi Iyer, Michael A. Labuzetta, Michael Ibara, Michael Celeste, George Getty, David W. Bates, Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting, Pharmacoepidemiology and Drug Safety, 2010, 19, 12
  61. 61
    Judith A. Racoosin, Melissa A. Robb, Rachel E. Sherman, Janet Woodcock, FDA's Sentinel Initiative: Active Surveillance to Identify Safety Signals,
  62. 62
    Gianluca Trifirò, Preciosa Coloma, Leveraging Routinely Collected Healthcare Data to Scale Up Drug Safety Surveillance: The EU-ADR Experience,